[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Subcutaneous Immunoglobulins Market Report 2017

November 2017 | 103 pages | ID: U21BD0A194CEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Subcutaneous Immunoglobulins market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Subcutaneous Immunoglobulins in these regions, from 2012 to 2022 (forecast).
United States Subcutaneous Immunoglobulins market competition by top manufacturers/players, with Subcutaneous Immunoglobulins sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Grifols S.A
  • Octopharma AG
  • Biotest AG
  • Shire
  • CSL Ltd
  • Kedrion S.p.A.
  • Sanquin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Immunoglobulin A
  • Immunoglobulin E
  • Immunoglobulin G
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Immunology
  • Oncology
  • Pulmonology
  • Rheumatology
  • Transplant
  • Neurology
  • Hematology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Subcutaneous Immunoglobulins Market Report 2017

1 SUBCUTANEOUS IMMUNOGLOBULINS OVERVIEW

1.1 Product Overview and Scope of Subcutaneous Immunoglobulins
1.2 Classification of Subcutaneous Immunoglobulins by Product Category
  1.2.1 United States Subcutaneous Immunoglobulins Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Subcutaneous Immunoglobulins Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Immunoglobulin A
  1.2.4 Immunoglobulin E
  1.2.5 Immunoglobulin G
  1.2.6 Others
1.3 United States Subcutaneous Immunoglobulins Market by Application/End Users
  1.3.1 United States Subcutaneous Immunoglobulins Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Immunology
  1.3.3 Oncology
  1.3.4 Pulmonology
  1.3.5 Rheumatology
  1.3.6 Transplant
  1.3.7 Neurology
  1.3.8 Hematology
  1.3.9 Others
1.4 United States Subcutaneous Immunoglobulins Market by Region
  1.4.1 United States Subcutaneous Immunoglobulins Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
  1.4.3 Southwest Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
  1.4.5 New England Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
  1.4.6 The South Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
  1.4.7 The Midwest Subcutaneous Immunoglobulins Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Subcutaneous Immunoglobulins (2012-2022)
  1.5.1 United States Subcutaneous Immunoglobulins Sales and Growth Rate (2012-2022)
  1.5.2 United States Subcutaneous Immunoglobulins Revenue and Growth Rate (2012-2022)

2 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Subcutaneous Immunoglobulins Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Subcutaneous Immunoglobulins Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Subcutaneous Immunoglobulins Average Price by Players/Suppliers (2012-2017)
2.4 United States Subcutaneous Immunoglobulins Market Competitive Situation and Trends
  2.4.1 United States Subcutaneous Immunoglobulins Market Concentration Rate
  2.4.2 United States Subcutaneous Immunoglobulins Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Subcutaneous Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Subcutaneous Immunoglobulins Sales and Market Share by Region (2012-2017)
3.2 United States Subcutaneous Immunoglobulins Revenue and Market Share by Region (2012-2017)
3.3 United States Subcutaneous Immunoglobulins Price by Region (2012-2017)

4 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Subcutaneous Immunoglobulins Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Subcutaneous Immunoglobulins Revenue and Market Share by Type (2012-2017)
4.3 United States Subcutaneous Immunoglobulins Price by Type (2012-2017)
4.4 United States Subcutaneous Immunoglobulins Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Subcutaneous Immunoglobulins Sales and Market Share by Application (2012-2017)
5.2 United States Subcutaneous Immunoglobulins Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Grifols S.A
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Grifols S.A Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Octopharma AG
  6.2.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Octopharma AG Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Biotest AG
  6.3.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Biotest AG Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Shire
  6.4.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Shire Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CSL Ltd
  6.5.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSL Ltd Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Kedrion S.p.A.
  6.6.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion S.p.A. Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanquin
  6.7.2 Subcutaneous Immunoglobulins Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanquin Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 SUBCUTANEOUS IMMUNOGLOBULINS MANUFACTURING COST ANALYSIS

7.1 Subcutaneous Immunoglobulins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Subcutaneous Immunoglobulins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Subcutaneous Immunoglobulins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Subcutaneous Immunoglobulins Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SUBCUTANEOUS IMMUNOGLOBULINS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Subcutaneous Immunoglobulins Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Subcutaneous Immunoglobulins Sales Volume Forecast by Type (2017-2022)
11.3 United States Subcutaneous Immunoglobulins Sales Volume Forecast by Application (2017-2022)
11.4 United States Subcutaneous Immunoglobulins Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Subcutaneous Immunoglobulins
Figure United States Subcutaneous Immunoglobulins Market Size (K MT) by Type (2012-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunoglobulin A Product Picture
Figure Immunoglobulin E Product Picture
Figure Immunoglobulin G Product Picture
Figure Others Product Picture
Figure United States Subcutaneous Immunoglobulins Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Subcutaneous Immunoglobulins by Application in 2016
Figure Immunology Examples
Table Key Downstream Customer in Immunology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Pulmonology Examples
Table Key Downstream Customer in Pulmonology
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Transplant Examples
Table Key Downstream Customer in Transplant
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Hematology Examples
Table Key Downstream Customer in Hematology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Subcutaneous Immunoglobulins Market Size (Million USD) by Region (2012-2022)
Figure The West Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Subcutaneous Immunoglobulins Sales (K MT) and Growth Rate (2012-2022)
Figure United States Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Subcutaneous Immunoglobulins Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Subcutaneous Immunoglobulins Sales Share by Players/Suppliers
Figure 2017 United States Subcutaneous Immunoglobulins Sales Share by Players/Suppliers
Figure United States Subcutaneous Immunoglobulins Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Subcutaneous Immunoglobulins Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Subcutaneous Immunoglobulins Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Subcutaneous Immunoglobulins Revenue Share by Players/Suppliers
Figure 2017 United States Subcutaneous Immunoglobulins Revenue Share by Players/Suppliers
Table United States Market Subcutaneous Immunoglobulins Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Subcutaneous Immunoglobulins Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Subcutaneous Immunoglobulins Market Share of Top 3 Players/Suppliers
Figure United States Subcutaneous Immunoglobulins Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Subcutaneous Immunoglobulins Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Subcutaneous Immunoglobulins Product Category
Table United States Subcutaneous Immunoglobulins Sales (K MT) by Region (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales Share by Region (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Share by Region (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Market Share by Region in 2016
Table United States Subcutaneous Immunoglobulins Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Subcutaneous Immunoglobulins Revenue Share by Region (2012-2017)
Figure United States Subcutaneous Immunoglobulins Revenue Market Share by Region (2012-2017)
Figure United States Subcutaneous Immunoglobulins Revenue Market Share by Region in 2016
Table United States Subcutaneous Immunoglobulins Price (USD/MT) by Region (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales (K MT) by Type (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales Share by Type (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Share by Type (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Market Share by Type in 2016
Table United States Subcutaneous Immunoglobulins Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Subcutaneous Immunoglobulins Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Subcutaneous Immunoglobulins by Type (2012-2017)
Figure Revenue Market Share of Subcutaneous Immunoglobulins by Type in 2016
Table United States Subcutaneous Immunoglobulins Price (USD/MT) by Types (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Growth Rate by Type (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales (K MT) by Application (2012-2017)
Table United States Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Market Share by Application in 2016
Table United States Subcutaneous Immunoglobulins Sales Growth Rate by Application (2012-2017)
Figure United States Subcutaneous Immunoglobulins Sales Growth Rate by Application (2012-2017)
Table Grifols S.A Basic Information List
Table Grifols S.A Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Grifols S.A Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Octopharma AG Basic Information List
Table Octopharma AG Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Octopharma AG Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Biotest AG Basic Information List
Table Biotest AG Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Biotest AG Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Shire Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table CSL Ltd Basic Information List
Table CSL Ltd Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure CSL Ltd Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Kedrion S.p.A. Basic Information List
Table Kedrion S.p.A. Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Kedrion S.p.A. Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Sanquin Basic Information List
Table Sanquin Subcutaneous Immunoglobulins Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Sales Growth Rate (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Sales Market Share in United States (2012-2017)
Figure Sanquin Subcutaneous Immunoglobulins Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Subcutaneous Immunoglobulins
Figure Manufacturing Process Analysis of Subcutaneous Immunoglobulins
Figure Subcutaneous Immunoglobulins Industrial Chain Analysis
Table Raw Materials Sources of Subcutaneous Immunoglobulins Major Players/Suppliers in 2016
Table Major Buyers of Subcutaneous Immunoglobulins
Table Distributors/Traders List
Figure United States Subcutaneous Immunoglobulins Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Subcutaneous Immunoglobulins Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Subcutaneous Immunoglobulins Price (USD/MT) Trend Forecast (2017-2022)
Table United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Type in 2022
Table United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Application in 2022
Table United States Subcutaneous Immunoglobulins Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Subcutaneous Immunoglobulins Sales Volume Share Forecast by Region (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume Share Forecast by Region (2017-2022)
Figure United States Subcutaneous Immunoglobulins Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories